Skip to main content

Table 4 Comparison of AV VD of CAS group A versus CAS group B patients. Patients with CAS 0–2 were categorized as group A and scored three or more as group B. (AV: all vessels; VD: vessel density; SD: Standard Deviation; TED: thyroid eye disease; CAS: Clinical Activity Score)

From: Optic nerve head optical coherence tomography angiography findings in patients with thyroid eye disease: a case–control study

  CAS group A
(n:18)
Mean ± SD
(Range)
CAS group B
(n:11)
Mean ± SD
(Range)
P Value
Whole image AV VD 57.45 ± 1.33
(55.10–60.10)
54.83 ± 3.07
(46.70–59.50)
0.005
Inside disc AV VD 59.20 ± 2.81
(55.20–64.40)
56.33 ± 5.59
(45.50–67.80)
0.087
Whole peripapillary AV VD 60.31 ± 1.25
(57.60–62)
57.33 ± 4.08
(45.70–61.10)
0.010
Peripapillary superior hemifield AV VD 60.86 ± 1.30
(57.90–62.80)
58.10 ± 4.03
(46.70–61.60)
0.016
Peripapillary inferior hemifield AV VD 59.70 ± 1.66
(56.80–62.30)
56.49 ± 4.21
(44.70–60.60)
0.010
Grid based superotemporal AV VD 58.57 ± 3.27
(49.80–63.30)
57.05 ± 5.77
(44.00–64.60)
0.375
Grid based temporal AV VD 56.90 ± 3.17
(52.60–62.60)
56.21 ± 4.31
(46.40–61.70)
0.623
Grid based inferotemporal AV VD 58.91 ± 3.46
(50.70–62.70)
57.84 ± 5.46
(45.60–66.30)
0.523
Grid based superior AV VD 57.89 ± 5.82
(43–63)
55.80 ± 4.41
(47.30–61.70)
0.306
Grid based central AV VD 60.40 ± 2.51
(56.10–65.50)
58.52 ± 5.29
(50.30–67.40)
0.272
Grid based inferior AV VD 61.81 ± 2.37
(57.80–65.30)
61.61 ± 3.87
(54.30–66.10)
0.875
Grid based superonasal AV VD 52.01 ± 5.03
(40.60–61.60)
49.45 ± 5.13
(38.90–57.60)
0.193
Grid based nasal AV VD 55.06 ± 3.06
(48.90–59.80)
50.35 ± 4.50
(42.40–57.10)
0.002
Grid based inferonasal AV VD 50.97 ± 4.32
(43.20–60.10)
46.77 ± 4.06
(38.60–52.10)
0.014